X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2023-05-05 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $350.00 | -3,272 | 32,038 | -9% | -$1,145,213 | |||||
M | 2023-05-02 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $350.71 | -4,403 | 35,310 | -11% | -$1,544,187 | |||||
2023-04-12 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $326.70 | -7,567 | 39,713 | -16% | -$2,472,164 | ||||||
2023-04-04 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $315.81 | -522 | 47,280 | -1% | -$164,854 | ||||||
2023-03-16 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $300.59 | -2,746 | 49,268 | -5% | -$825,423 | ||||||
2023-02-14 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $300.40 | -2,181 | 59,734 | -4% | -$655,161 | ||||||
2023-02-13 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $300.39 | -113 | 61,915 | 0% | -$33,944 | ||||||
2023-01-31 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $325.00 | -106 | 37,998 | 0% | -$34,450 | ||||||
2022-11-02 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $312.64 | -320 | 38,104 | -1% | -$100,045 | ||||||
2022-10-18 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $300.31 | -1,791 | 39,192 | -4% | -$537,860 | ||||||
2022-05-16 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $252.83 | -45 | 41,749 | 0% | -$11,377 | ||||||
2022-05-04 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $275.09 | -36 | 41,660 | 0% | -$9,903 | ||||||
2022-05-02 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $259.16 | -320 | 41,696 | -1% | -$82,930 | ||||||
2022-04-07 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $276.18 | -561 | 42,782 | -1% | -$154,935 | ||||||
M | 2022-04-04 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $274.10 | -3,725 | 43,343 | -8% | -$1,021,005 | |||||
2022-03-17 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $250.06 | -2,122 | 48,412 | -4% | -$530,627 | ||||||
2022-02-02 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $250.98 | -1,040 | 54,952 | -2% | -$261,017 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |